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Background: Prognosis of ST-elevation myocardial infarction (STEMI) is determined
predominantly by the extent of myocardial damage and hemodynamic status. Thus, in
previous studies patients with proximal LAD occlusion have had worse outcome than
those with more distal LAD lesions. It is not known whether modern reperfusion therapy
has altered this relationship.
Methods: The INFUSE-AMI trial randomized patients with anterior STEMI due to
proximal or mid LAD occlusion to intracoronary bolus abciximab delivered locally via
the ClearWay RX catheter vs. no abciximab, and to manual thrombus aspiration with the
Export catheter vs. no aspiration. The primary endpoint was core laboratory assessed MRI
infarct size (IS, % of LV mass) at 30 days. Lesion location was assessed at a core
laboratory blinded to randomization and outcomes and was defined as proximal (pLAD)
if present before or at first significant septal perforator branch, or mid (mLAD) if beyond
it.
Results: The study enrolled 452 patients. The median age was 61y, 74% were men and
11% had diabetes. Intracoronary abciximab reduced IS (% LV mass): 15.1[6.8-22.7] vs.
17.9[10.3-25.4], P0.03. Thrombectomy had no effect on IS. There were 292 (64.7%)
patients with pLAD and 159 (35.3%) with mLAD occlusion. Patients with pLAD
presented more often within 3h of symptom onset and had lower systolic blood pressure,
but did not differ from mLAD patients with respect to heart rate, Killip class or extent of
coronary disease. Thrombectomy was performed in 49.3% and 56.0% of the two groups,
P0.18 and intracoronary abciximab was used in 46.9% and 47.2%, respectively,
P0.79. Reperfusion succes, infarct size and major clinical outcomes are listed in Table.
Conclusions: These data confirm the excess risk of death associated with pLAD infarcts
even with contemporary reperfusion therapy. Reduced TIMI 3 flow rates and larger IS in
pLAD infarcts translate into increased mortality.
Proximal LAD Mid LAD P value
Final TIMI 3 flow, % 89.4 95.0 0.04
Final blush score 2 or
3, %
82.1 79.9 0.56
Corrected TIMI frame
counts
20[16, 26] 20[16,26] 0.78
ST segment
resolution, %
72[49, 86] 72[41, 92] 0.93
Procedure success, % 87.2 94.3 0.02
Infarct size, % of LV
at 30 days
19.3[9.2, 25.9] 14.3[6.2, 18.9] 0.0001
Death at 30 days, % 4.2 0.6 0.04
Stent thrombosis,
definite/probable, %
1.4 0 0.14
MACCE (death,
infarction, stroke,
revascularization)
4.8 2.6 0.24
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Background: Thromboaspiration (TA) during primary percutaneous intervention (PPCI)
is effective in opening the infarct-related artery in patients with ST-segment elevation
myocardial infarction (STEMI), leading to better reperfusion and improved outcome.
However, the effect of positive macroscopic efficiency of TA remains unknown. We
aimed to evaluate the impact of positive thrombus retrieval during PPCI with manual TA
on infarct size (IS) and microvascular obstruction (MVO) as assessed by contrast-
enhanced magnetic resonance imaging (CE-MRI) in a subset of patients with STEMI.
Methods: Inclusion criteria were patients aged75 years, with first STEMI referred for
PPCI within 12 hours of onset of symptoms, infarct-related artery 2.5 mm in diameter,
thrombus score 3 and no prior history of coronary disease. All patients underwent TA
before stenting and were categorized according to positive or negative TA. Clinical and
procedural characteristics of study population were recorded and CE-MRI was performed
at 5 days and 6-months to evaluate MVO and IS.
Results: 88 patients were enrolled, mean age 5510 years; 43.1% in the positive TA group.
Main results are presented in the table. Clinical and procedural characteristics (90-min total
ischemic time, ST-segment resolution, post-procedural TIMI flow grade and post-stenting
myocardial blush grade, and peak troponin) did not differ significantly between groups.
Independent predictors of final IS were: positive TA (OR 0.34, 95%CI 0.03-0.71), MVO (OR
1.75, 95%CI 1.28-0.71) and IS at 5 days (OR 2.06, 95%CI 1.87-3.32).
Negative
TA (N50)
Positive TA
(N38) p
Microvascular obstruction (%) 7.65.1 3.83.1 0.003
Infarct size in the acute phase (%) 28.220.8 14.98.7 0.004
Final Infarct size at 6 months (%) 22.319.3 12.08.3 0.002
Conclusions: Positive thrombus retrieval during primary PPCI with manual TA in
STEMI reduces MVO and in the acute phase and at 6 months and represents a powerful
predictor of final infarct size.
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Background: In early studies, reinfarction after primary angioplasty occurred relatively
frequently and was an important cause of mortality in STEMI. The frequency, timing and
implications of reinfarction in the contemporary primary PCI era have not been described.
Methods: In HORIZONS-AMI, 3,602 pts with STEMI at 123 sites were randomized to
heparin 	 glycoprotein IIb/IIIa inhibitor (GPI) vs. bivalirudin, and to paclitaxel-eluting
stents vs. bare metal stents (BMS). Clinical FU was conducted for 3 years.
Results: Stents were implanted in 3,202 pts, comprising the current study cohort.
Reinfarction within 3 years occurred in 221 pts (6.9%) at median [IQR] 244 [22, 573]
days. Reinfarction developed within 30 days in 59 pts (27.0%); thereafter the incident rate
of reinfarction was linear and constant until 3 years, with no plateau evident. Of note,
definite stent thrombosis was responsible for 115 of the 221 reinfarctions (52.0%). The
unadjusted 3-year reinfarction rate was lower in pts assigned to bivalirudin vs. heparin	
GPI (6.3% vs. 8.3%, p0.04), but was not different with DES vs. BMS (7.0% vs. 8.1%,
p0.31). By multivariable analysis, independent predictors of reinfarction were current
smoking (P0.009), Killip class 1 (P0.03), stent length (P0.006), platelet count
(P0.0003), symptom to balloon time (P0.02), multivessel disease (P0.0004) and
prior MI (P0.0001). At 3 years, pts with vs without reinfarction had higher unadjusted
rates of cardiac death (9.8% vs. 3.2%, P0.0001) and all-cause mortality (13.1% vs.
5.8%, P0.0001). In a time and covariate adjusted Cox multivariable model, reinfarction
was an independent predictor of 3-year cardiac death (HR[95%CI]  8.39 [4.77, 14.77],
P0.0001) and all-cause mortality (HR[95%CI]  3.25 [1.98, 5.35], P0.0001).
Conclusions: Despite improvements in drugs and devices, reinfarction after primary PCI
still occurs relatively frequently with both BMS and DES; is often due to stent thrombosis;
and is strongly associated with subsequent cardiac death and all-cause mortality. Safer
stents and more effective antithrombotic agents are required to prevent reinfarction and
further improve outcomes in STEMI.
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Background: Despite recovered normal epicardial coronary flow after primary percutaneous
coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), micro-
vascular damage and dysfunction limit the effect of primary PCI. The purpose of this study was
to evaluate whether manual thrombectomy can preserve the index of microcirculatory
resistance (IMR) after primary PCI in patients with anterior STEMI.
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Methods: 41consecutive patients (38 men and 3 women; age 52 9 years) with anterior
STEMI were enrolled. All patients were randomized into two groups and underwent
primary PCI for anterior STEMI: stenting after manual thrombectomy (aspiration group,
n22) and stenting without manual thrombectomy (conventional group, n19). The
thermodilution-derived coronary flow reserve (CFR) and index of microcirculatory
resistance (IMR) were measured by using the pressure-temperature sensor-tipped coro-
nary wire at the left anterior descending artery (LAD) after primary PCI. Baseline
echocardiography was performed before discharge and follow-up echocardiography was
performed 6 months later.
Results: There was no significant difference in reperfusion time (onset to balloon time)
and CFR (2.01  1.1 vs. 2.08  1.1, p  0.831), baseline ejection fraction (EF, 44.5 
7.5% vs. 48.0 8.0%, p 0.15), baseline wall motion score index (WMSI, 1.52 0.32
vs. 1.46  0.31, p  0.59) between two groups. But, there was significant difference in
IMR (22.3 8.7 vs. 29.5 11.9, p 0.037), EF (follow up EF – baseline EF, 5.86
7.2 vs. 1.29 2.5, p 0.011), WMSI (baseline WMSI – follow up WMSI,0.199
0.242 vs. 0.003  0.075, p  0.001) between two groups.
Conclusions: Compared with conventional PCI, manual thrombectomy before stenting
for patients with anterior STEMI seems to preserve microvascular integrity. Manual
thrombectomy as an adjunctive method of primary PCI for acute anterior STEMI might
have beneficial efficacy on myocardial microcirculation.
TCT-471
The Impact Of First- versus Second-Generation Drug-Eluting Stents On
Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment
Elevation Myocardial Infarction Population
Joshua Loh1, Hironori Kitabata1, Israel Barbash2, Danny Dvir3, Salem Badr2,
Rebecca Torguson3, Kenneth Kent4, Lowell Satler5, William Suddath2,
Augusto Pichard6, Ron Waksman7
1Medstar Washington Hospital Center, Washington, DC, 2Washington Hospital
Center, Washington, DC, 3Washington Hospital center, washington, DC,
4Washington Hospital center, Washington, DC, 5Washington hospital center,
washington, DC, 6washsington hospital center, Washington, USA, 7Georgtown
University, Washington, DC
Background: Drug-eluting stents (DES) are used in ST-segment elevation myocardial
infarction (STEMI) patients with good safety and efficacy, even in complex patient
subsets. This study aimed to compare the in-hospital and 1-year outcomes of STEMI
patients with complex clinical and angiographic characteristics treated with 1st- versus
2nd-generation DES.
Methods: The study included 524 consecutive STEMI patients with1 of the following
characteristics: Ejection fraction (EF) 30%, chronic renal insufficiency (CRI), cardio-
genic shock, bifurcation, unprotected left main, totally occluded, ACC/AHA Type C,
bypass graft, in-stent restenosis, presence of thrombus, 1 lesion treated, and stent
implantation length 28 mm. Clinical outcomes of patients treated with 1st-generation
DES (Cypher/Taxus) (n452) were compared to those treated with 2nd-generation DES
(Promux/Xience) (n102).
Results: Baseline demographics were similar in patients treated with 1st- vs. 2nd-
generation DES. Mean age was 62.2  12.5 years; 65% males; mean EF was 42  13
%; and 13.1% had CRI. IABP use (14.2% overall), procedure time (50 51 min overall),
lesion locations, graft and in-stent restenosis lesions were also similar. 2nd-generation
DES were used more frequently in Type C lesions (56.8 vs. 27.4 %, p0.001) and distal
lesions (25.2 vs. 13.8 %, p0.001). The number of implanted DES was 1.5  0.8
overall. Angiographic success was similar at 99.4% overall. There was no difference in
composite major in-hospital complications. 1-year mortality, revascularization, and major
adverse cardiac event rates were similar in both groups.(Table)
1st
generation
DES
2nd
generation
DES
P value(n452) (n102)
In-hospital Death 4.2 (19) 1 (1) 0.146
In-hospital Q-wave MI 0.4 (2) 0 (0) 1
In-hospital Urgent CABG 0.4 (2) 4 (4) 0.012
In-hospital Stent thrombosis 0.4 (2) 0 (0) 1
Major in-hospital complications
(death/QWMI/CABG)
4.9 (22) 4.9 (5) 1
1-year Death 10.3 (46) 6.9 (7) 0.305
1-year Q-wave MI 0.2 (19) 1 (1) 0.339
1-year Target Lesion
Revascularization
5.2 (22) 4.1 (4) 0.8
1-year Target Vessel
Revascularization
9.2 (39) 8.2 (8) 0.747
1-year Stent thrombosis 0.9 (4) 0 (0) 1
1-year MACE (Death/QWMI/
TVR)
17.9 (81) 14.7 (15) 0.438
Conclusions: Despite the presence of higher lesion complexity, the use of 2nd-generation
DES in a STEMI population with complex clinical and angiographic characteristics
results in similarly low rates of in-hospital and 1-year outcomes when compared to
1st-generation DES.
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Background: Troponin elevation is a risk factor for mortality in pts with non
ST-segment elevation acute coronary syndromes (NSTEACS). However, prognostic
impact of non-obstructive coronary artery disease (CAD) in NSTEACS pts with troponin
elevation is unknown.
Methods: In the ACUITY trial, 3-vessel quantitative coronary angiography was
performed in a formal substudy of 6,921 pts with moderate and high-risk NSTEACS.
Patients with elevated admission troponin levels ( local upper limit of normal) were
stratified by the presence or absence of obstructive CAD (any lesion with diameter
stenosis (DS) 50%). Propensity-score matching was performed to adjust for baseline
characteristics.
Results: Of 2,442 patients with elevated troponins, 197 (8.8%) had non-obstructive
CAD. Maximum DS was 83.5%  17.5 vs. 24.1%  12.2 (p0.0001) in pts with vs.
without obstructive CAD. Propensity score matching yielded 117 patients with non-
obstructive CAD and 351 patients with obstructive CAD with no significant baseline
differences including renal function and diabetes. Overall 1-year mortality was signifi-
cantly higher in pts with non-obstructive CAD (5.2% vs 1.2%; HR [95%CI]  4.57
[1.29,16.21], p0.01), driven mainly by higher non-cardiac mortality (Table). Con-
versely, recurrent MI and unplanned revascularization rates were higher in patients with
obstructive CAD.
Non-
obstructive
CAD
(n117)
Obstructive
CAD
(n351)
Relative Risk
[95% CI] P-Value
1 Month Outcomes
Death 2.6% (3) 0.3% (1) 9.07 [0.94,87.15] 0.02
Cardiac death 0.9% (1) 0.3% (1) 3.02 [0.19,48.24] 0.41
Non-cardiac death 1.7% (2) 0.0% (0) N/A 0.01
Recurrent MI 0.9% (1) 6.3% (22) 0.13 [0.02,1.00] 0.02
Unplanned revascularization 0.0% (0) 3.7% (13) N/A 0.04
Major bleeding 5.2% (6) 6.0% (21) 0.86 [0.35,2.12] 0.74
CVA/TIA 0.0% (0) 0.3% (1) N/A 1.00
1-Year Outcomes
Death 5.2% (6) 1.2% (4) 4.57 [1.29,16.21] 0.01
Cardiac death 1.7% (2) 0.9% (3) 2.03 [0.34,12.16] 0.43
Non-cardiac death 3.5% (4) 0.3% (1) 12.20 [1.4,109.1] 0.004
Recurrent MI 3.6% (4) 9.0% (31) 0.38 [0.13,1.08] 0.058
Unplanned revascularization 0.0% (0) 9.2% (31) N/A 0.001
CVA/TIA 0.0% (0) 0.3% (1) N/A 1.00
Conclusions: Patients presenting with NSTEACS symptoms and elevated troponin
levels in whom obstructive CAD is absent, are at significantly higher risk of 1-year
all-cause and non-cardiac mortality than those with obstructive CAD, despite lower rates
of unplanned revascularization and subsequent MI. Troponin elevation in pts with
non-obstructive CAD may be an important risk factor for mortality, prompting a
comprehensive search for an alternative diagnosis.
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Background: Mortality amongst emergency medical admissions has been reported to be
higher when patients are admitted to hospital at nights and weekends. We studied the
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